General Oncology News

American Society of Clinical Oncology Reports on Clinical Cancer Advances for 2019

American Society of Clinical Oncology Reports on Clinical Cancer Advances for 2019

The American Society of Clinical Oncology has selected "Progress in Treating Rare Cancers" as the 2019 Advance of the Year.

The Incidence of Some Obesity-Related Cancers Is Increasing Among Young Adults

The Incidence of Some Obesity-Related Cancers Is Increasing Among Young Adults

Obesity in childhood and adolescence may be related to the disproportionate rise in certain obesity-related cancers in younger adults, according to authors.

Immune Checkpoint Inhibitor Therapy and Risk of Tuberculosis Exacerbation

Immune Checkpoint Inhibitor Therapy and Risk of Tuberculosis Exacerbation

Immune checkpoint therapy with programmed cell death-1 (PD-1) inhibitors was linked to activation of latent Mycobacterium tuberculosis (Mtb) infection in 2 patients.

Alternative Approach Proposed for Assessing Long-Term Benefit of ICIs

Alternative Approach Proposed for Assessing Long-Term Benefit of ICIs

Researchers propose a way to determine the long-term benefit of immune checkpoint inhibitors that differs from the approach in the ASCO Value Framework.

Intravenous Administration Could Be Key to Peptide-Based Cancer Vaccines

Intravenous Administration Could Be Key to Peptide-Based Cancer Vaccines

Administration of vaccines via the unconventional intravenous route conferred greater antitumor activity in mice than the traditional subcutaneous route.

Birinapant Found to Enhance Antitumor Activity of CAR-T in Solid Tumor Models

Birinapant Found to Enhance Antitumor Activity of CAR-T in Solid Tumor Models

This study provides evidence that birinapant could enhance sensitivity to TNF, effectively boosting the activity of CAR-T therapy in solid tumors.

Illumina's TruSight Next-Generation Sequencing Assay Receives FDA Breakthrough Device Designation

Illumina's TruSight Next-Generation Sequencing Assay Receives FDA Breakthrough Device Designation

Illumina's TruSight Oncology 500 next-generation sequencing assay has been assigned a breakthrough device status by the FDA.

CS/HIPEC Deemed Safer Than Other High-Risk Cancer Surgeries

CS/HIPEC Deemed Safer Than Other High-Risk Cancer Surgeries

The perception that there are high surgical complication rates with CS/HIPEC in peritoneal metastasis may be inaccurate.

No Association Between Patient Sex and Efficacy of Immunotherapy: Study

No Association Between Patient Sex and Efficacy of Immunotherapy: Study

A study found no significant association between patient sex and efficacy of immunotherapy in patients with advanced cancers, contradicting previous evidence.

Tumor Mutational Burden as a Predictor of Response to Immunotherapy

Tumor Mutational Burden as a Predictor of Response to Immunotherapy

A single definition of TMB as a predictor of survival benefit from immune checkpoint inhibitors across cancer types is not feasible, according to authors.

Immunotherapy Plus Chemotherapy May Turn Cold Tumors Hot

Immunotherapy Plus Chemotherapy May Turn Cold Tumors Hot

Immune checkpoint blockade combined with chemotherapy may sensitize "cold" tumors to immunotherapy and lead to enhanced responses.

Spending on Medical DTC Advertising Increased Dramatically Over the Past 20 Years

Spending on Medical DTC Advertising Increased Dramatically Over the Past 20 Years

The spend on medical marketing in the United States has dramatically grown over a 20-year span, but drug marketing as a proportion of total US drug spending decreased.

Study Shows Prevalence of Lynch Syndrome in Solid Tumors Through MSI Status

Study Shows Prevalence of Lynch Syndrome in Solid Tumors Through MSI Status

The findings suggest that changes in genetic testing criteria are warranted.

Appropriate Integration of Radiotherapy in Cancer Care: A Call to Action From Researchers

Appropriate Integration of Radiotherapy in Cancer Care: A Call to Action From Researchers

A report highlights the current gap in the utilization of radiotherapy in Europe and outlines an action plan as a solution.

Study Identifies Factors for Reducing Febrile Neutropenia

Study Identifies Factors for Reducing Febrile Neutropenia

Disruptions in barrier integrity, use of corticosteroids, and use of intravenous antibiotics prior to chemotherapy may increase risk of febrile neutropenia.

Progression-Free Survival and Patient Quality of Life Are Not One and the Same

Progression-Free Survival and Patient Quality of Life Are Not One and the Same

To make informed treatment decisions, the affect a drug has on a patient's quality of life must be considered, investigators argued.

cfDNA Holds Great Potential to Transform Cancer Medicine

cfDNA Holds Great Potential to Transform Cancer Medicine

Integration of liquid biopsies will require understanding of their advantages and limitations.

Thoracic US Score Predicts Pleurodesis Success in Malignant Pleural Effusion

Thoracic US Score Predicts Pleurodesis Success in Malignant Pleural Effusion

A pleural adherence score derived from thoracic ultrasound at 24 hours post-talc administration is predictive of long-term pleurodesis success in patients with symptomatic malignant pleural effusion.

5 Key Findings Presented at the 2018 World Cancer Congress

5 Key Findings Presented at the 2018 World Cancer Congress

Health experts from around the world shared research at the 2018 World Cancer Congress. We recapped 5 key findings presented at the event.

Commission Calls for Integration of Oncology and Palliative Care

Commission Calls for Integration of Oncology and Palliative Care

A recent Lancet Oncology Commission laid out why oncology and palliative care should be integrated and how to achieve successful integration despite barriers.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs